Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Delmer

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Diagnostics (Basel, Switzerland)|July 14, 2023
Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab MaintenanceCarole Durot, Eric Durot, Sébastien Mulé, et al.
Annals of Nuclear Medicine|May 25, 2021
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphomaDavid Morland, Ghali Zizi, François Godard, et al.
Infectious Diseases (London, England)|May 12, 2017
Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentrationMaxime Hentzien, Christophe Strady, Véronique Vernet-Garnier, et al.
Cancer|December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study GroupIrene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
British Journal of Haematology|March 19, 2016
Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantationAnne Quinquenel, Flore Sicre de Fontbrune, Eric Durot, et al.
British Journal of Haematology|August 26, 2004
A new acute lymphoblastic leukaemia cell line BEL-1 with t(4; 11) (q21; q23) chromosomal translocation and a unique aberrant p27 transcriptRuoping Tang, Anne-Marie Faussat, Jean-Yves Perrot, et al.
British Journal of Clinical Pharmacology|April 23, 2015
Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemiaSarit Assouline, Valeria Buccheri, Alain Delmer, et al.
Journal of Chemotherapy (Florence, Italy)|October 10, 2018
Pulmonary adverse events related to idelalisib therapy: A single centre experienceCaroline Migault, Delphine Lebrun, Olivier Toubas, et al.
British Journal of Haematology|May 10, 2017
Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptationAudrey Bidet, Claudine Chollet, Martine Gardembas, et al.
Annales De Biologie Clinique|June 11, 2013
[Brain abscess due to Nocardia cyriacigeorgica simulating an ischemic stroke]Emmanuelle Lavalard, Thomas Guillard, Sonia Baumard, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Diagnostics (Basel, Switzerland)|July 14, 2023
Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab MaintenanceCarole Durot, Eric Durot, Sébastien Mulé, et al.
Annals of Nuclear Medicine|May 25, 2021
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphomaDavid Morland, Ghali Zizi, François Godard, et al.
Infectious Diseases (London, England)|May 12, 2017
Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentrationMaxime Hentzien, Christophe Strady, Véronique Vernet-Garnier, et al.
Cancer|December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study GroupIrene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
British Journal of Haematology|March 19, 2016
Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantationAnne Quinquenel, Flore Sicre de Fontbrune, Eric Durot, et al.
British Journal of Haematology|August 26, 2004
A new acute lymphoblastic leukaemia cell line BEL-1 with t(4; 11) (q21; q23) chromosomal translocation and a unique aberrant p27 transcriptRuoping Tang, Anne-Marie Faussat, Jean-Yves Perrot, et al.
British Journal of Clinical Pharmacology|April 23, 2015
Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemiaSarit Assouline, Valeria Buccheri, Alain Delmer, et al.
Journal of Chemotherapy (Florence, Italy)|October 10, 2018
Pulmonary adverse events related to idelalisib therapy: A single centre experienceCaroline Migault, Delphine Lebrun, Olivier Toubas, et al.
British Journal of Haematology|May 10, 2017
Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptationAudrey Bidet, Claudine Chollet, Martine Gardembas, et al.
Annales De Biologie Clinique|June 11, 2013
[Brain abscess due to Nocardia cyriacigeorgica simulating an ischemic stroke]Emmanuelle Lavalard, Thomas Guillard, Sonia Baumard, et al.
Pageof 11